SCHEMBL3960064

SCHEMBL3960064

CCOC(COc1ccc(C(F)(F)F)cc1)COc1ccc(O)c(C)c1

nearest known ligand 0.67

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 16/20 0.67
PPARA Q07869 1/20 0.53
ESR1 P03372 2/20 0.42
AR P10275 1/20 0.42
ESR2 Q92731 1/20 0.42
FFAR1 O14842 2/20 0.41
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019616 0.86 PPARD (0.72) PPARDPPARA
SCHEMBL7021758 0.85 PPARD (0.49) PPARDESR1ARESR2
SCHEMBL13680168 0.85 PPARD (0.51) PPARDPPARAFFAR1PPARG
SCHEMBL7019114 0.85 PPARD (0.77) PPARDPPARA
SCHEMBL3960058 0.85 PPARD (0.67) PPARDPPARAFFAR1PPARG
SCHEMBL7016586 0.84 PPARD (0.72) PPARDPPARA
SCHEMBL14355031 0.81 PPARD (0.72) PPARDPPARA
SCHEMBL377558 0.80 PPARD (1.00) PPARDPPARA
SCHEMBL17920520 0.79 PPARD (0.56) PPARDPPARAPPARG
SCHEMBL7018887 0.79 PPARD (0.81) PPARDPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667964-B1 4-((PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS JANSSEN PHARMACEUTICA NV (BE) 2009-07-22 EP claimed
US-20120122988-A1 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS CYMABAY THERAPEUTICS, INC. 2012-05-17 US disclosed
EP-2100877-A1 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs Janssen Pharmaceutica, N.V. (BE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122988-A1 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS PPARA, PPARG, PPARD PPARD 3/4885PPARA 1/4885ESR1 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.